Infectious Disease Diagnostics Market by Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza), End User - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Infectious Disease Diagnostics Market, By Product

7.1.  Infectious Disease Diagnostics Market, By Product, 2021-2027

7.1.1.     Reagents, Kits, and Consumables

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Instruments

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Software & Services

7.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Infectious Disease Diagnostics Market, By Type of Testing

8.1.  Infectious Disease Diagnostics Market, By Type of Testing, 2021-2027

8.1.1.     Laboratory Testing

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     POC Testing

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Infectious Disease Diagnostics Market, By Technology

9.1.  Infectious Disease Diagnostics Market, By Technology, 2021-2027

9.1.1.     Immunodiagnostics

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Clinical Microbiology

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     DNA Sequencing & NGS

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     DNA Microarrays

9.1.4.1.          Market Revenue and Forecast (2016-2027)

9.1.5.     Other technologies

9.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Infectious Disease Diagnostics Market, By Disease Type

10.1.          Infectious Disease Diagnostics Market, By Disease Type, 2021-2027

10.1.1.  COVID-19

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  HIV

10.1.2.1.       Market Revenue and Forecast (2016-2027)

10.1.3.  HAIs

10.1.3.1.       Market Revenue and Forecast (2016-2027)

10.1.4.  Hepatitis

10.1.4.1.       Market Revenue and Forecast (2016-2027)

10.1.5.  CT/NG

10.1.5.1.       Market Revenue and Forecast (2016-2027)

10.1.6.  HPV

10.1.6.1.       Market Revenue and Forecast (2016-2027)

10.1.7.  TB

10.1.7.1.       Market Revenue and Forecast (2016-2027)

10.1.8.  Influenza

10.1.8.1.       Market Revenue and Forecast (2016-2027)

10.1.9.  Other Infectious Diseases

10.1.9.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Infectious Disease Diagnostics Market, By End User

11.1.          Infectious Disease Diagnostics Market, By End User, 2021-2027

11.1.1.  Diagnostic Laboratories

11.1.1.1.       Market Revenue and Forecast (2016-2027)

11.1.2.  Hospitals & Clinics

11.1.2.1.       Market Revenue and Forecast (2016-2027)

11.1.3.  Hospitals & Clinics

11.1.3.1.       Market Revenue and Forecast (2016-2027)

11.1.4.  Hospitals & Clinics

11.1.4.1.       Market Revenue and Forecast (2016-2027)

Chapter 12.Global Infectious Disease Diagnostics Market, Regional Estimates and Trend Forecast

12.1.          North America

12.1.1.  Market Revenue and Forecast, By Product (2016-2027)

12.1.2.  Market Revenue and Forecast, By Type of Testing (2016-2027)

12.1.3.  Market Revenue and Forecast, By Technology (2016-2027)

12.1.4.  Market Revenue and Forecast, By Disease Type (2016-2027)

12.1.5.  Market Revenue and Forecast, By End User (2016-2027)

12.1.6.  U.S.

12.1.6.1.       Market Revenue and Forecast, By Product (2016-2027)

12.1.6.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.1.6.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.1.6.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.1.6.5.       Market Revenue and Forecast, By End User (2016-2027)

12.1.7.  Rest of North America

12.1.7.1.       Market Revenue and Forecast, By Product (2016-2027)

12.1.7.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.1.7.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.1.7.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.1.7.5.       Market Revenue and Forecast, By End User (2016-2027)

12.2.          Europe

12.2.1.  Market Revenue and Forecast, By Product (2016-2027)

12.2.2.  Market Revenue and Forecast, By Type of Testing (2016-2027)

12.2.3.  Market Revenue and Forecast, By Technology (2016-2027)

12.2.4.  Market Revenue and Forecast, By Disease Type (2016-2027)

12.2.5.  Market Revenue and Forecast, By End User (2016-2027)

12.2.6.  UK

12.2.6.1.       Market Revenue and Forecast, By Product (2016-2027)

12.2.6.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.2.6.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.2.6.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.2.6.5.       Market Revenue and Forecast, By End User (2016-2027)

12.2.7.  Germany

12.2.7.1.       Market Revenue and Forecast, By Product (2016-2027)

12.2.7.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.2.7.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.2.7.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.2.7.5.       Market Revenue and Forecast, By End User (2016-2027)

12.2.8.  France

12.2.8.1.       Market Revenue and Forecast, By Product (2016-2027)

12.2.8.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.2.8.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.2.8.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.2.8.5.       Market Revenue and Forecast, By End User (2016-2027)

12.2.9.  Rest of Europe

12.2.9.1.       Market Revenue and Forecast, By Product (2016-2027)

12.2.9.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.2.9.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.2.9.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.2.9.5.       Market Revenue and Forecast, By End User (2016-2027)

12.3.          APAC

12.3.1.  Market Revenue and Forecast, By Product (2016-2027)

12.3.2.  Market Revenue and Forecast, By Type of Testing (2016-2027)

12.3.3.  Market Revenue and Forecast, By Technology (2016-2027)

12.3.4.  Market Revenue and Forecast, By Disease Type (2016-2027)

12.3.5.  Market Revenue and Forecast, By End User (2016-2027)

12.3.6.  India

12.3.6.1.       Market Revenue and Forecast, By Product (2016-2027)

12.3.6.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.3.6.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.3.6.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.3.6.5.       Market Revenue and Forecast, By End User (2016-2027)

12.3.7.  China

12.3.7.1.       Market Revenue and Forecast, By Product (2016-2027)

12.3.7.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.3.7.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.3.7.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.3.7.5.       Market Revenue and Forecast, By End User (2016-2027)

12.3.8.  Japan

12.3.8.1.       Market Revenue and Forecast, By Product (2016-2027)

12.3.8.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.3.8.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.3.8.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.3.8.5.       Market Revenue and Forecast, By End User (2016-2027)

12.3.9.  Rest of APAC

12.3.9.1.       Market Revenue and Forecast, By Product (2016-2027)

12.3.9.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.3.9.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.3.9.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.3.9.5.       Market Revenue and Forecast, By End User (2016-2027)

12.4.          MEA

12.4.1.  Market Revenue and Forecast, By Product (2016-2027)

12.4.2.  Market Revenue and Forecast, By Type of Testing (2016-2027)

12.4.3.  Market Revenue and Forecast, By Technology (2016-2027)

12.4.4.  Market Revenue and Forecast, By Disease Type (2016-2027)

12.4.5.  Market Revenue and Forecast, By End User (2016-2027)

12.4.6.  GCC

12.4.6.1.       Market Revenue and Forecast, By Product (2016-2027)

12.4.6.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.4.6.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.4.6.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.4.6.5.       Market Revenue and Forecast, By End User (2016-2027)

12.4.7.  North Africa

12.4.7.1.       Market Revenue and Forecast, By Product (2016-2027)

12.4.7.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.4.7.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.4.7.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.4.7.5.       Market Revenue and Forecast, By End User (2016-2027)

12.4.8.  South Africa

12.4.8.1.       Market Revenue and Forecast, By Product (2016-2027)

12.4.8.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.4.8.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.4.8.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.4.8.5.       Market Revenue and Forecast, By End User (2016-2027)

12.4.9.  Rest of MEA

12.4.9.1.       Market Revenue and Forecast, By Product (2016-2027)

12.4.9.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.4.9.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.4.9.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.4.9.5.       Market Revenue and Forecast, By End User (2016-2027)

12.5.          Latin America

12.5.1.  Market Revenue and Forecast, By Product (2016-2027)

12.5.2.  Market Revenue and Forecast, By Type of Testing (2016-2027)

12.5.3.  Market Revenue and Forecast, By Technology (2016-2027)

12.5.4.  Market Revenue and Forecast, By Disease Type (2016-2027)

12.5.5.  Market Revenue and Forecast, By End User (2016-2027)

12.5.6.  Brazil

12.5.6.1.       Market Revenue and Forecast, By Product (2016-2027)

12.5.6.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.5.6.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.5.6.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.5.6.5.       Market Revenue and Forecast, By End User (2016-2027)

12.5.7.  Rest of LATAM

12.5.7.1.       Market Revenue and Forecast, By Product (2016-2027)

12.5.7.2.       Market Revenue and Forecast, By Type of Testing (2016-2027)

12.5.7.3.       Market Revenue and Forecast, By Technology (2016-2027)

12.5.7.4.       Market Revenue and Forecast, By Disease Type (2016-2027)

12.5.7.5.       Market Revenue and Forecast, By End User (2016-2027)

Chapter 13.   Company Profiles

13.1.                 Abbott Laboratories

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.                 Becton Dickinson and Company

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.                 BioMerieus SA

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.                 Bio-Rad Laboratories

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.                 Danaher Corporation

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.                 F Hoffman-La Roche  

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.                 Hologic Inc.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.                 Luminex Corporation

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.                 Qiagen Inc.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.              Thermo Fisher Scientific Inc

13.10.1.                   Company Overview

13.10.2.                   Product Offerings

13.10.3.                   Financial Performance

13.10.4.                   Recent Initiatives

Chapter 14.   Research Methodology

14.1.                 Primary Research

14.2.                 Secondary Research

14.3.                 Assumptions

Chapter 15.   Appendix

15.1.                 About Us

15.2.                 Glossary of Terms